Celldex Therapeutics Inc. (CLDX)

5.92
0.07 1.17
NASDAQ : Health Technology
Prev Close 5.99
Open 5.97
Day Low/High 5.76 / 6.07
52 Wk Low/High 0.26 / 42.90
Volume 236.66K
Avg Volume 3.12M
Exchange NASDAQ
Shares Outstanding 12.12M
Market Cap 68.60M
EPS -10.80
Div & Yield N.A. (N.A)
Celldex Reports Fourth Quarter And Year-End 2015 Results

Celldex Reports Fourth Quarter And Year-End 2015 Results

Conference Call Scheduled for 8:00 a.m. ET Today

First Week of April 15th Options Trading For Celldex Therapeutics (CLDX)

First Week of April 15th Options Trading For Celldex Therapeutics (CLDX)

Investors in Celldex Therapeutics, Inc. saw new options become available this week, for the April 15th expiration.

Today's Weak On High Volume Stock: Celldex Therapeutics (CLDX)

Today's Weak On High Volume Stock: Celldex Therapeutics (CLDX)

Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a weak on high relative volume candidate

'Mad Money' Lightning Round: I'm Not Going Against Amgen

'Mad Money' Lightning Round: I'm Not Going Against Amgen

Cramer is concerned about Omega Healthcare, expects a healthy quarter for Fitbit and isn't recommending Tesoro.

Jim Cramer's 'Mad Money' Recap: Time to Start Buying Cheap Stocks

Jim Cramer's 'Mad Money' Recap: Time to Start Buying Cheap Stocks

Now's the time to roll up your sleeves and figure out what to buy, Cramer says. That job has been made easier by a strong earnings season.

Celldex To Report Fourth Quarter And Year-End 2015 Business/Financial Results And Host 2016 Corporate Strategy Conference Call

Celldex To Report Fourth Quarter And Year-End 2015 Business/Financial Results And Host 2016 Corporate Strategy Conference Call

--Conference Call Scheduled for Thursday, February 25 at 8:00 a.m. Eastern Time--

Celldex Therapeutics is Now Oversold

Celldex Therapeutics is Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Celldex Therapeutics (CLDX) In A Perilous Reversal

Celldex Therapeutics (CLDX) In A Perilous Reversal

Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a "perilous reversal" (up big yesterday but down big today) candidate

Trade-Ideas: Celldex Therapeutics (CLDX) Is Today's "Dead Cat Bounce" Stock

Trade-Ideas: Celldex Therapeutics (CLDX) Is Today's "Dead Cat Bounce" Stock

Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a "dead cat bounce" (down big yesterday but up big today) candidate

Weak On High Volume: Celldex Therapeutics (CLDX)

Weak On High Volume: Celldex Therapeutics (CLDX)

Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a weak on high relative volume candidate

Celldex Nears Pivotal Decision Point for Brain Tumor Therapy

Celldex Nears Pivotal Decision Point for Brain Tumor Therapy

Celldex will announce the outcome of an interim analysis for a pivotal study of its brain tumor therapy Rintega within weeks.

Oversold Conditions For Celldex Therapeutics (CLDX)

Oversold Conditions For Celldex Therapeutics (CLDX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Celldex Therapeutics (CLDX) Highlighted As Weak On High Volume

Celldex Therapeutics (CLDX) Highlighted As Weak On High Volume

Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a weak on high relative volume candidate

8 Things That Could Lift Biotech Stocks Out of Bear Market

8 Things That Could Lift Biotech Stocks Out of Bear Market

Biotech stocks are buried in a deep hole. To climb out, companies will have to generate some positive news.

New 52-Week Low Could Prompt More Insider Buying At CLDX

New 52-Week Low Could Prompt More Insider Buying At CLDX

In trading on Thursday, shares of Celldex Therapeutics, Inc. touched a new 52-week low of $9.66/share.

'Mad Money' Lightning Round: Buy, Buy, Buy Cedar Fair for the Yield

'Mad Money' Lightning Round: Buy, Buy, Buy Cedar Fair for the Yield

Cramer sees First Solar going higher and wants no part of Atwood Oceanics.

Jim Cramer's 'Mad Money' Recap: Oil Is What's Fueling This Market

Jim Cramer's 'Mad Money' Recap: Oil Is What's Fueling This Market

Until oil prices stabilize, don't expect any meaningful relief in the stock market, Cramer says.

Celldex Therapeutics (CLDX) Highlighted As Weak On High Volume

Celldex Therapeutics (CLDX) Highlighted As Weak On High Volume

Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a weak on high relative volume candidate

Today's Dead Cat Bounce Stock: Celldex Therapeutics (CLDX)

Today's Dead Cat Bounce Stock: Celldex Therapeutics (CLDX)

Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a "dead cat bounce" (down big yesterday but up big today) candidate

Cancer Immunotherapy ETF Offers High Growth Investing Potential

Cancer Immunotherapy ETF Offers High Growth Investing Potential

Immunotherapy is changing the way the medical community thinks about treating cancer.

Trade-Ideas: Celldex Therapeutics (CLDX) Is Today's "Dead Cat Bounce" Stock

Trade-Ideas: Celldex Therapeutics (CLDX) Is Today's "Dead Cat Bounce" Stock

Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a "dead cat bounce" (down big yesterday but up big today) candidate

Celldex Therapeutics (CLDX) Strong On High Relative Volume Today

Celldex Therapeutics (CLDX) Strong On High Relative Volume Today

Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a strong on high relative volume candidate

Trade-Ideas: Celldex Therapeutics (CLDX) Is Today's "Perilous Reversal" Stock

Trade-Ideas: Celldex Therapeutics (CLDX) Is Today's "Perilous Reversal" Stock

Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a "perilous reversal" (up big yesterday but down big today) candidate

4 Big-Volume Stocks to Trade for Big Gains

4 Big-Volume Stocks to Trade for Big Gains

Here's how to trade four stocks spiking on increased trading volume.

Celldex Therapeutics (CLDX) Strong On High Relative Volume Today

Celldex Therapeutics (CLDX) Strong On High Relative Volume Today

Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a strong on high relative volume candidate

Barbarian At The Gate: Celldex Therapeutics (CLDX)

Barbarian At The Gate: Celldex Therapeutics (CLDX)

Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate

TheStreet Quant Rating: D- (Sell)